Induction of myocardial neoangiogenesis by human growth factors. A new therapeutic option in coronary heart disease;Induktion der myokardialen neoangiogenese durch humane wachstumsfaktoren. Ein neuer therapieansatz bei koronarer Herzkrankheit

Herz

Volumn 25, Issue 6, 2000, Pages 589-599

  Stegmann, Thomas J ^a   Hoppert, Thomas ^a   Schneider, André ^a   Gemeinhardt, Stefan ^a   Köcher, Michael ^a   Ibing, Rainer ^a   Strupp, Gerhard ^a  

^a KLINIKUM FULDA   (Germany)

Author keywords

Angiogenesis; Coronary heart disease; Growth factors

Indexed keywords

ANGIOGENIC FACTOR; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 1; GROWTH FACTOR; OXYGEN; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CAPILLARY DENSITY; CARDIOVASCULAR DISEASE; DRUG EFFECT; GENE THERAPY; HEART INFARCTION; HEART MUSCLE OXYGEN CONSUMPTION; HEART PERFUSION; HUMAN; ISCHEMIC HEART DISEASE; PERIPHERAL VASCULAR DISEASE;

EID: 0033810282     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/pl00001972     Document Type: Article

References (64)

1. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischaemia: Dose-response effect of basic fibroblast growth factor
2. Acidic fibroblast growth factor (FGF) from bovine brain: Amino-terminal sequence and comparison with basic FGF
3. Effects of acidic fibroblast growth factor on normal and ischaemic myocardium
4. Up-regulation of vascular endothelial growth factor expression induced by myocardial ischaemia: Implications for coronary angiogenesis
5. Angiogenic-induced enhancement of collateral flow to ischaemic myocardium by vascular endothelial growth factor in dogs
6. Intracoronary injection of basic fibroblast growth factor enhances angiogenesis in infarcted swine myocardium
7. Constitutive expression of ph VEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischaemia
8. Multiple forms of endothelial cell growth factor. Rapid isolation and biological and chemical characterization
9. A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment
10. Vascular permeability factor/vascular endothelial growth factor, micro-vascular hyperpermeability and angiogenesis
11. Experimental use of a modified fibrin-glue to induce site-directed angiogenesis from the aorta to the heart
12. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
13. Tumour angiogenesis: Therapeutic implications
14. Angiogenic factors
15. Angiogenesis
16. Clinical applications of research on angiogenesis
17. Angiogenic therapy of the human heart
18. Therapeutic angiogenesis in ischaemic limbs
19. The characterization of the receptor for endothelial cell growth factor by covalent ligand attachment
20. Endothelial regeneration and turnover: Studies with human endothelial cell cultures
21. Intracoronary transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischaemic region of the heart
22. Basic fibroblast growth factor improves myocardial function in chronically ischaemic porcine hearts
23. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions
24. Clinical evidence of angiogenesis after arterial gene transfer of ph VEGF165 in patient with ischaemic limb
25. Cancer and atherosclerosis. The broad mandate of angiogenesis
26. Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells
27. Induction of angiogenesis by smooth muscle cell-derived factor: Possible role in neovascularization in atherosclerotic plaque
28. Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery
29. Gene therapy for myocardial angiogenesis. Initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischaemia
30. Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart
31. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury
32. Heparin binds endothelial cell growth factor, the principal mitogen in the bovine brain
33. Salvage angiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischaemic vascular occlusion
34. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apoliprotein E-deficient mice
35. Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo
36. Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxia-induced proliferation of endothelial cells and pericytes
37. Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis
38. Angiogenesis and growth factor expression in a model of transmyocardial revascularization
39. Angiogenesis gene therapy
40. Growth of 'new' coronary vascular structures by angiogenetic growth factors
41. Induction of neoangiogenesis in ischaemic myocardium by human growth factors. First clinical results of a new treatment of coronary heart disease
42. The stimulation of neoangiogenesis in the ischaemic human head by the growth factor FGF: First clinical results
43. Angiogenesis induced by acidic fibroblast growth factor as an alternative method of revascularization for chronic myocardial ischaemia
44. Therapeutic angiogenesis with basic fibroblast growth factor: Technique and early results
45. Heparin affinity: Purification of a tumour-derived capillary endothelial cell growth factor
46. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
47. Fibroblast growth factors: At the heart of angiogenesis
48. Two sides of the same coin. Stop angiogenesis for cancer and encourage it for coronary artery disease
49. FGF-1: A human growth factor in the induction of neoangiogenesis
50. New approaches to coronary heart disease: Induction of neovascularization by growth factors
51. Combined local angiogenesis and surgical revascularization for coronary artery disease
52. Intramyocardial injection of acidic fibroblast growth factor: Adjunct to bypass surgery and monotherapy for coronary heart disease
53. First angiogenic treatment of coronary heart disease by FGF-1: Long-term results after three years
54. Therapeutic angiogenesis, Single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischaemic hind limb model
55. Protamine is an inhibitor of angiogenesis
56. Vascular endothelial growth factor, a potent and selective angiogenetic agent
57. Heparin-binding growth factor induces the formation of organoid neovascular structures in vivo
58. Increased gene expression for VEGF and the VEGF receptors KDT/FIk and Fit in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide
59. Basic fibroblast growth factor enhances myocardial collateral flow in a canine model
60. Functional upregulation of the vascular endothelial growth factor receptor KDR by hypoxia
61. Angiogenesis in ischaemic heart disease
62. A novel heart derived inhibitor of vascular cell proliferation. Purification and biological activity
63. Treatment of pulmonary haemangiomatosis with recombinant interferon alfa-2a
64. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor